definiens: shall mean any and all expense s incurred in ( i ) maintaining the LICENSED TECHNOLOGY, ( ii ) prosecuting the LICENSED TECHNOLOG Y, ( iii ) developing the LICENSED TECHNOLOGY including direct expenses related to res earch and development, clinical trials, marketing a nd distribution, and miscellaneous expenses including samples, returns, direct selling expenses, and ( iv ) indirect expenses and ( v ) administrative expenses, 1.9 shall mean any and al l forms of value and consideration which LANTERN may realize ( i ) from the development, manufacture, licensing and exploitation of LICENSED TECHNOLOGY ; ( ii ) possession, use, sale, manufacture or import o f TARGETED COMPOUNDS ; or ( iii ) grant of or forbeara nce to grant sublicenses or forbearance to manufacture with respect to the TARGETED COMPOUNDS and any NON - CASH CONSIDERATION for the TARGETED COMPOUNDS, excluding ( iv ) grants from non - profit organizations